![Logo for Roivant Sciences Ltd](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F8400b-2023-08-15-10-05-21.png&w=256&q=100)
Roivant Sciences Investor Relations Material
Latest events
![Logo for Roivant Sciences Ltd](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F8400b-2023-08-15-10-05-21.png&w=128&q=100)
Q4 2024
Roivant Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Roivant Sciences Ltd
Access all reports
Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company established in 2014, dedicated to the development and commercialization of innovative medicines and technologies, particularly in the areas of inflammation and immunology. The company adopts a unique model, creating nimble and focused subsidiaries known as "Vants" for the development and commercialization of its medicines and technologies. This model has enabled Roivant to bring to market treatments like VTAMA® (tapinarof cream, 1%) for plaque psoriasis in adults, and to advance a diverse pipeline of investigational drugs across its family of companies, including fully human monoclonal antibodies and treatments for autoimmune diseases. Roivant Sciences is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Key slides for Roivant Sciences Ltd
![What Do " Roivant -](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Froivant-sciences-ltd-the-jp-morgan-42nd-annual-healthcare-conference-2024-295d0db4202ed33b%2F18.png&w=3840&q=75)
![Logo for Roivant Sciences Ltd](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F8400b-2023-08-15-10-05-21.png&w=128&q=100)
The J.P. Morgan 42nd Annual Healthcare Conference 2024
Roivant Sciences Ltd
![Renegotiation of Der](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Froivant-sciences-ltd-q4-2024-f489087fe02012f9%2F23.png&w=3840&q=75)
![Logo for Roivant Sciences Ltd](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F8400b-2023-08-15-10-05-21.png&w=128&q=100)
Q4 2024
Roivant Sciences Ltd
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F1882x1059%2F7e17876154%2Fbirkin.png&w=3840&q=75)
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2688x1512%2F8365aa8316%2Ftop-10-largest-semiconductor-companies.png&w=3840&q=75)
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F135c0e3f6b%2Fthe-rise-of-nubank.png&w=3840&q=75)
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
ROIV
Country
🇺🇸 United States